1. Overexpression of CD168 is related to poor prognosis in oral squamous cell carcinoma
   Su‐Wen Zhu et al, 2022, Oral Diseases CrossRef
2. Development of Exhaustion and Acquisition of Regulatory Function by Infiltrating CD8+CD28− T Lymphocytes Dictate Clinical Outcome in Head and Neck Cancer
   Daniela Fenoglio et al, 2021, Cancers CrossRef
3. RB Loss Promotes Prostate Cancer Metastasis
   Chellappagounder Thangavel et al, 2017, Cancer Research CrossRef
4. Carbon anhydrase IX specific immune responses in patients with metastatic renal cell carcinoma potentially cured by interleukin-2 based immunotherapy
   Susanne Rasmussen et al, 2013, Immunopharmacology and Immunotoxicology CrossRef
5. Prognostic significance of receptor for hyaluronan acid-mediated motility (CD168) in acute pediatric leukemias – assessment of clinical outcome, post induction, end of treatment and minimal residual disease
   Chinnathambi Narayanan Sai Shalini et al, 2018, Hematology, Transfusion and Cell Therapy CrossRef
6. Hyaluronic acid–paclitaxel conjugate inhibits growth of human squamous cell carcinomas of the head and neck via a hyaluronic acid-mediated mechanism
   Chad E. Galer et al, 2011, Oral Oncology CrossRef
7. Expression of the receptor for hyaluronic acid mediated motility (RHAMM) is associated with poor prognosis and metastasis in non-small cell lung carcinoma
   Dunrui Wang et al, 2016, Oncotarget CrossRef
8. In situ RHAMM protein expression in acute myeloid leukemia blasts suggests poor overall survival
   Alexandar Tzankov et al, 2011, Annals of Hematology CrossRef
9. Role of receptor for hyaluronan-mediated motility (RHAMM) in human head and neck cancers
   Hideo Shigeishi et al, 2014, Journal of Cancer Research and Clinical Oncology CrossRef
10. Serum Carbonic Anhydrase IX and Its Prognostic Relevance in Vulvar Cancer
    Lilli Kock et al, 2011, International Journal of Gynecologic Cancer CrossRef
11. Carbonic anhydrase IX in tumor tissue and sera of patients with primary cervical cancer
    Linn Woelber et al, 2011, BMC Cancer CrossRef
12. Comprehensive Bioinformatics Analysis to Identify the Gene HMMR Associated With Lung Adenocarcinoma Prognosis and Its Mechanism of Action in Multiple Cancers
    Jianguang Shi et al, 2021, Frontiers in Oncology CrossRef
13. Involvement of histone deacetylation in MORC2-mediated down-regulation of carbonic anhydrase IX
    Yangguang Shao et al, 2010, Nucleic Acids Research CrossRef
14. RHAMM (CD168) Is Overexpressed at the Protein Level and May Constitute an Immunogenic Antigen in Advanced Prostate Cancer Disease
    Kilian M. Gust et al, 2009, Neoplasia CrossRef
15. Frequent T cell responses against immunogenic targets in lung cancer patients for targeted immunotherapy
    ANNA BABIAK et al, 2014, Oncology Reports CrossRef
16. The clinical implications of antitumor immunity in head and neck cancer
    Clint T. Allen et al, 2012, The Laryngoscope CrossRef
17. Expression patterns of CD168 correlate with the stage and grade of squamous cell carcinoma of head and neck
    Korinna Jöhrens et al, 2017, Molecular and Clinical Oncology CrossRef
18. Tumor vaccines in 2010: Need for integration
    David Koos et al, 2010, Cellular Immunology CrossRef
19. High Expression of Hyaluronan-Mediated Motility Receptor Predicts Adverse Outcomes: A Potential Therapeutic Target for Head and Neck Squamous Cell Carcinoma
    Tianzhu Lu et al, 2021, Frontiers in Oncology CrossRef
20. Immunotherapy for Lung Cancers
    Ming-Yi Ho et al, 2011, Journal of Biomedicine and Biotechnology CrossRef
21. ELISPOT Assay for Monitoring Cytotoxic T Lymphocytes (CTL) Activity in Cancer Vaccine Clinical Trials
    Anatoli M. Malyguine et al, 2012, Cells CrossRef
22. The role of carbonic anhydrase IX in hypoxia control in OSCC
    Mario Pérez‐Sayáns et al, 2013, Journal of Oral Pathology & Medicine CrossRef